Amini, M. R., Sheikhhossein, F., Naghshi, S., Djafari, F., Askari, M., Shahinfar, H., . . . Shab-Bidar, S. (2020). Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine, 49, 102337. doi:10.1016/j.ctim.2020.102337
Asbaghi, O., Ghanbari, N., Shekari, M., Reiner, Ž., Amirani, E., Hallajzadeh, J., . . . Asemi, Z. (2020). The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 38, 43–49. doi:10.1016/j.clnesp.2020.04.010
Avila-Carrasco, L., García-Mayorga, E. A., Díaz-Avila, D. L., Garza-Veloz, I., Martinez-Fierro, M. L., & González-Mateo, G. T. (2021). Potential therapeutic effects of natural plant compounds in kidney disease. Molecules, 26(20). doi:10.3390/molecules26206096
Beba, M., Djafarian, K., & Shab-Bidar, S. (2019). Effect of berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine, 46, 81–86. doi:10.1016/j.ctim.2019.08.002
Blais, J. E., Huang, X., & Zhao, J. V. (2023). Overall and sex-specific effect of berberine for the treatment of dyslipidemia in adults: A systematic review and meta-analysis of randomized placebo-controlled trials. Drugs, 83(5), 403–427. doi:10.1007/s40265-023-01841-4
Chen, C., Lin, Q., Zhu, X. Y., Xia, J., Mao, T., Chi, T., . . . Li, D. (2021). Pre-clinical evidence: Berberine as a promising cardioprotective candidate for myocardial ischemia/reperfusion injury, a systematic review, and meta-analysis. Frontiers in Cardiovascular Medicine, 8, 646306. doi:10.3389/fcvm.2021.646306
Cheng, M., Liu, R., Wu, Y., Gu, P., Zheng, L., Liu, Y., . . . Ding, L. (2016). LC-MS/MS determination and urinary excretion study of seven alkaloids in healthy Chinese volunteers after oral administration of shuanghua baihe tablets. Journal of Pharmaceutical and Biomedical Analysis, 118, 89–95. doi:10.1016/j.jpba.2015.10.014
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., . . . Banach, M. (2017). Lipid-lowering nutraceuticals in clinical practice: Position paper from an international lipid expert panel. Nutrition Reviews, 75(9), 731–767. doi:10.1093/nutrit/nux047
Fan, J., Zhang, K., Jin, Y., Li, B., Gao, S., Zhu, J., & Cui, R. (2019). Pharmacological effects of berberine on mood disorders. Journal of Cellular and Molecular Medicine, 23(1), 21–28. doi:10.1111/jcmm.13930
Fogacci, F., Grassi, D., Rizzo, M., & Cicero, A. F. G. (2019). Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Phytotherapy Research, 33(4), 862–870. doi:10.1002/ptr.6282
Funk, R. S., Singh, R. K., Winefield, R. D., Kandel, S. E., Ruisinger, J. F., Moriarty, P. M., & Backes, J. M. (2018). Variability in potency among commercial preparations of berberine. Journal of Dietary Supplements, 15(3), 343–351. doi:10.1080/19390211.2017.1347227
Guo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., . . . Liu, W. J. (2021). The effect of berberine on metabolic profiles in type 2 diabetic patients: A systematic review and meta-analysis of randomized controlled trials. Oxidative Medicine and Cellular Longevity, 2021, 2074610. doi:10.1155/2021/2074610
Guo, Y., Chen, Y., Tan, Z. R., Klaassen, C. D., & Zhou, H. H. (2012). Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology 68(2), 213–217. doi:10.1007/s00228-011-1108-2
Hao, Y., Li, J., Yue, S., Wang, S., Hu, S., & Li, B. (2022). Neuroprotective effect and possible mechanisms of berberine in diabetes-related cognitive impairment: A systematic review and meta-analysis of animal studies. Frontiers in Pharmacology, 13, 917375. doi:10.3389/fphar.2022.917375
Hernandez, A. V., Hwang, J., Nasreen, I., Sicignano, D., Pasupuleti, V., Snow-Caroti, K., & White, C. M. (2023). Impact of berberine or berberine combination products on lipoprotein, triglyceride and biological safety marker concentrations in patients with hyperlipidemia: A systematic review and meta-analysis. Journal of Dietary Supplements, 1–18. doi:10.1080/19390211.2023.2212762
Hu, S., Wang, J., Liu, E., Zhang, X., Xiang, J., Li, W., . . . Ma, X. (2022). Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action. Pharmacological Research, 185, 106481. doi:10.1016/j.phrs.2022.106481
Hu, S., Wei, P., Li, W., Liu, Q., Chen, S., Hu, C., . . . Zhang, Y. (2022). Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies. Frontiers in Pharmacology, 13, 937029. doi:10.3389/fphar.2022.937029
Huang, Z. J., Zeng, Y., Lan, P., Sun, P. H., & Chen, W. M. (2011). Advances in structural modifications and biological activities of berberine: An active compound in traditional Chinese medicine. Mini-Reviews in Medicinal Chemistry, 11(13), 1122–1129. doi:10.2174/138955711797655362
Ilyas, Z., Perna, S., Al-Thawadi, S., Alalwan, T. A., Riva, A., Petrangolini, G., . . . Rondanelli, M. (2020). The effect of berberine on weight loss in order to prevent obesity: A systematic review. Biomedicine & Pharmacotherapy, 127, 110–137. doi:10.1016/j.biopha.2020.110137
Jia, D., Zhang, X., Guo, Q., Yang, R., Yu, H., Zhao, M., . . . Zhang, D. (2022). Efficacy and underlying mechanism of berberine against atherosclerosis: A meta-analysis in preclinical animal studies. Journal of Cardiovascular Pharmacology, 80(3), 476–488. doi:10.1097/fjc.0000000000001308
Khalili, L., Centner, A. M., & Salazar, G. (2023). Effects of berries, phytochemicals, and probiotics on atherosclerosis through gut microbiota modification: A meta-analysis of animal studies. International Journal of Molecular Sciences, 24(4). doi:10.3390/ijms24043084
Lan, J., Zhao, Y., Dong, F., Yan, Z., Zheng, W., Fan, J., & Sun, G. (2015). Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology, 161, 69–81. doi:10.1016/j.jep.2014.09.049
Liang, Y., Xu, X., Yin, M., Zhang, Y., Huang, L., Chen, R., & Ni, J. (2019). Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: A systematic literature review and a meta-analysis. Endocrine Journal, 66(1), 51–63. doi:10.1507/endocrj.EJ18-0109
Lu, Y., Zhang, X., He, J., Dai, Z., Shi, P., Lu, Y., & Chang, F. (2022). The effects of berberine on inflammatory markers in Chinese patients with metabolic syndrome and related disorders: A meta‑analysis of randomized controlled trials. Inflammopharmacology, 30(3), 1063–1077. doi:10.1007/s10787-022-00976-2
Mohtashaminia, F., Amini, M. R., Sheikhhossein, F., Djafarian, K., & Shab-Bidar, S. (2022). Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN, 49, 181–186. doi:10.1016/j.clnesp.2022.01.037
Moon, J. M., Ratliff, K. M., Hagele, A. M., Stecker, R. A., Mumford, P. W., & Kerksick, C. M. (2021). Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: A randomized, controlled, crossover pilot trial. Nutrients, 14(1). doi:10.3390/nu14010124
Osadnik, T., Goławski, M., Lewandowski, P., Morze, J., Osadnik, K., Pawlas, N., . . . Banach, M. (2022). A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. Pharmacological Research, 183, 106402. doi:10.1016/j.phrs.2022.106402
Suadoni, M. T., & Atherton, I. (2021). Berberine for the treatment of hypertension: A systematic review. Complementary Therapies in Clinical Practice, 42, 101287. doi:10.1016/j.ctcp.2020.101287
Wang, Y., Yan, A., Li, S., Liu, B., Li, H., & Yan, Y. (2019). Efficacy and safety of berberine in the treatment of type 2 diabetes with insulin resistance: Protocol for a systematic review. Medicine (Baltimore), 98(35), e16947. doi:10.1097/md.0000000000016947
Xie, W., Su, F., Wang, G., Peng, Z., Xu, Y., Zhang, Y., . . . Chen, R. (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology, 13, 1015045. doi:10.3389/fphar.2022.1015045
Xiong, P., Niu, L., Talaei, S., Kord-Varkaneh, H., Clark, C. C. T., Găman, M. A., . . . Zhang, J. (2020). The effect of berberine supplementation on obesity indices: A dose response meta-analysis and systematic review of randomized controlled trials. Complementary Therapies in Clinical Practice, 39, 101113. doi:10.1016/j.ctcp.2020.101113
Yang, L., Zhu, W., Zhang, X., Zhou, X., Wu, W., & Shen, T. (2023). Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine, 112, 154716. doi:10.1016/j.phymed.2023.154716
Ye, Y., Liu, X., Wu, N., Han, Y., Wang, J., Yu, Y., & Chen, Q. (2021). Efficacy and safety of berberine alone for several metabolic disorders: A systematic review and meta-analysis of randomized clinical trials. Frontiers in Pharmacology, 12, 653887. doi:10.3389/fphar.2021.653887
Yu, M., Jin, X., Liang, C., Bu, F., Pan, D., He, Q., . . . Fei, Y. (2020). Berberine for diarrhea in children and adults: A systematic review and meta-analysis. Therapeutic Advances in Gastroenterology, 13, 1756284820961299. doi:10.1177/1756284820961299
Zamani, M., Zarei, M., Nikbaf-Shandiz, M., Hosseini, S., Shiraseb, F., & Asbaghi, O. (2022). The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis. Frontiers in Nutrition, 9, 1013055. doi:10.3389/fnut.2022.1013055
Zhang, Y., Gu, Y., Ren, H., Wang, S., Zhong, H., Zhao, X., . . . Wang, W. (2020). Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (The PREMOTE study). Nature Communications, 11(1), 5015. doi:10.1038/s41467-020-18414-8